Accueil/Actions/INMB

INMB

USD

INmune Bio Inc. Common stock

$1.720-0.050 (-2.825%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$1.770

Haut

$1.790

Bas

$1.710

Volume

0.26M

Fondamentaux de l'Entreprise

Capitalisation Boursière

45.7M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.61M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.71Actuel $1.720Haut $11.64

Actualités Connexes

30 oct. 2025 · 20:05

GlobeNewswire

INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update

BOCA RATON, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient's innate

23 oct. 2025 · 11:00

GlobeNewswire

INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025

Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, Oct. 23, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) (the "Company"), INmune Bio Inc. (NASDAQ:INMB), a

14 oct. 2025 · 11:00

GlobeNewswire

INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025

Boca Raton, FL, Oct. 14, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ:INMB), a clinical-stage inflammation and immunology company, today announces that David Moss, Chief Executive Officer will participate in a